"Studies by Meng et al. and our group have reported that MenSCs from young and healthy women could increase to one doubling every 20 h supplied with sufficient culture conditions, which was twice as fast as BM-MSCs (estimated 40–45 h). MenSCs have similar phenotypes and properties compared with BM-MSCs, including spindles, classical three-line differentiation, and surface marker expression. A high rate of proliferation was contributed to the high expression of embryonic trophic factors and extracellular matrix (ECM) in MenSCs. A high proliferative capacity is critical for future clinical research because cell-based treatment is usually dose-dependent along with cells from the lower passages; therefore, increasing the yield of the preliminary cells is necessary and considerable in clinical research. In addition, MenSCs have been extensively expanded in vitro and hardly showed obvious chromosomal abnormalities by our group and others. Such a highly proliferating rate and stably genetic characteristic, as well as the apparent pluripotency, suggest that the novel stem cells may exhibit unexpected therapeutic properties. MenSCs are also remarkable for their broad differentiation capacity. Currently, MenSCs can be induced as endothelial, cardiomyocytic, neurocytic, cartilaginous, myocytic, respiratory epithelial, pancreatic, hepatic, adipocytic, and osteogenic parts using appropriate differentiation techniques. Hida et al. found that MenSCs exhibited cardiogenic differentiation in a scaffold culture system. Lai’s team has confirmed that the differentiation of MenSCs into germ cells was induced in the appropriate medium. Similarly, Liu et.al also proved that MenSCs had the capacity to differentiate into ovarian tissue-like cells. Furthermore, our group and Khanjani et al. have shown that MenSCs could differentiate into functional hepatocyte-like cells by checking mature hepatocyte functions. In addition, MenSCs had a potential for differentiation into glial lineages (neurosphere-like cells) by examining the expression of glial fibrillary acidic protein, oligosaccharide-2, and myelin basic protein."